切换至 "中华医学电子期刊资源库"

中华心脏与心律电子杂志 ›› 2023, Vol. 11 ›› Issue (02) : 105 -108. doi: 10.3877/cma.j.issn.2095-6568.2023.02.003

结构性心脏病

新型冠状病毒感染后经导管主动脉瓣置换术安全性分析
漆祎鸣, 潘文志, 朱风琴, 周达新(), 葛均波   
  1. 200032 上海,复旦大学附属中山医院心内科
    200231 上海,上海市徐汇区长桥街道社区卫生服务中心
  • 收稿日期:2023-03-03 出版日期:2023-06-25
  • 通信作者: 周达新
  • 基金资助:
    国家临床重点专科(YW2021-002)

Safety analysis of 19 cases of transcatheter aortic valve replacement after COVID-19 infection

Yiming Qi, Wenzhi Pan, Fengqin Zhu, Daxin Zhou(), Junbo Ge   

  1. Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China
    Changqiao Street Community Health Service Center, Shanghai 200031, China
  • Received:2023-03-03 Published:2023-06-25
  • Corresponding author: Daxin Zhou
引用本文:

漆祎鸣, 潘文志, 朱风琴, 周达新, 葛均波. 新型冠状病毒感染后经导管主动脉瓣置换术安全性分析[J/OL]. 中华心脏与心律电子杂志, 2023, 11(02): 105-108.

Yiming Qi, Wenzhi Pan, Fengqin Zhu, Daxin Zhou, Junbo Ge. Safety analysis of 19 cases of transcatheter aortic valve replacement after COVID-19 infection[J/OL]. Chinese Journal of Heart and Heart Rhythm(Electronic Edition), 2023, 11(02): 105-108.

目的

观察症状性主动脉瓣狭窄患者感染新型冠状病毒在抗原转阴后行经导管主动脉瓣置换术(TAVR)治疗的安全性。

方法

选取2022年12月9日至2023年1月13日在上海7家三甲医院行TAVR手术治疗的感染新型冠状病毒后抗原转阴15 d内的症状性重度主动脉瓣狭窄患者19例,总结患者术前一般情况、疾病史、术前检查、手术过程、术后检查、并发症情况和出院情况进行分析。

结果

2例患者为普通型新型冠状病毒肺炎,其余为轻型。所有患者均顺利完成手术,其中瓣中瓣植入1例。术后有3例患者因完全性房室传导阻滞行起搏器植入,1例患者出现脑卒中,无轻中度及以上瓣周漏、冠状动脉阻塞及死亡病例。

结论

症状性主动脉瓣狭窄患者在感染轻型或普通型新型冠状病毒肺炎后抗原转阴15 d内行TAVR手术是安全的。

Objective

To observe the safety of transcatheter aortic valve replacement (TAVR) for symptomatic aortic valve stenosis patients infected with Corona Virus Disease 2019 (COVID-19) and with negative antigen.

Methods

Ninteen patients with symptomatic severe aortic valve stenosis were performed TAVR in 7 hospitals in Shanghai from December 9th, 2022 to January 13th, 2023. The patients were infected with COVID-19 and the antigen turned negative within 15 days. The general conditions, disease history, preoperative examinations, procedures, postoperative examinations, complications and discharge conditions of the patients were summarized and analyzed.

Results

Two of the patients were ordinary COVID-19 pneumonia, and the rest were mild. All patients successfully completed the operation, including 1 case of valve-in-valve implantation. Three patients had pacemaker implantation due to complete atrioventricular block, and 1 patient had stroke after operation. There was no mild to moderate or above perivalvular leakage, coronary occlusion or death happened.

Conclusion

It is safe for symptomatic aortic valve stenosis patients to perform TAVR within 15 days after antigen negative conversion after infection with mild or common COVID-19 pneumonia.

表1 19例新型冠状病毒感染后症状性重度主动脉瓣狭窄患者基线资料
表2 19例新型冠状病毒感染后症状性重度主动脉瓣狭窄患者术后评估
[1]
Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor[J]. Cell, 2020, 181(2):271-280.e8.
[2]
Clerkin KJ, Fried JA, Raikhelkar J, et al. COVID-19 and cardiovascular disease[J]. Circulation, 2020, 141(20):1648-1655.
[3]
Zhai Z, Li C, Chen Y, et al. Prevention and treatment of venous thromboembolism associated with coronavirus disease 2019 infection: a consensus statement before guidelines[J]. Thromb Haemost, 2020, 120(6):937-948.
[4]
Elbaz-Greener G, Masih S, Fang J, et al. Temporal trends and clinical consequences of wait times for transcatheter aortic valve replacement: a population-based study[J]. Circulation, 2018, 138(5):483-493.
[5]
Ro R, Khera S, Tang G, et al. Characteristics and outcomes of patients deferred for transcatheter aortic valve replacement because of COVID-19[J]. JAMA Netw Open, 2020, 3(9):e2019801.
[6]
Giacomin E, Barioli A, Favero L, et al. Safety and feasibility of transcatheter aortic valve replacement in COVID-19 patients: a case series[J]. Cardiovasc Revasc Med, 2021, 28S:68-71.
[7]
Bauernschmitt R, Gabriel P, Gottardi R, et al. Valve-in-valve transcatheter aortic valve replacement in a young patient with a suspected COVID-19 infection: A surgical dilemma in the era of the COVID-19 pandemic[J]. Eur J Cardiothorac Surg, 2020, 58(1):188-189.
[8]
中华人民共和国国家卫生健康委员会办公厅, 中华人民共和国国家中医药管理局办公室. 新型冠状病毒肺炎诊疗方案(试行第九版)[J]. 中国医药, 2022, 17(4):481-487.
[9]
Shah PB, Welt F, Mahmud E, et al. Triage considerations for patients referred for structural heart disease intervention during the COVID-19 pandemic: An ACC/SCAI position statement[J]. JACC Cardiovasc Interv, 2020, 13(12):1484-1488.
[10]
Banerjee S, Tarantini G, Abu-Fadel M, et al. Coronavirus disease 2019 catheterization laboratory survey[J]. J Am Heart Assoc, 2020, 9(15):e017175.
[11]
Tarantini G, Nai Fovino L, Scotti A, et al. [Impact of COVID-19 pandemic on structural heart interventions in Italy][J]. G Ital Cardiol (Rome), 2020, 21(11 Suppl 1):45S-47S.
[12]
Faroux L, Chen S, Muntané-Carol G, et al. Clinical impact of conduction disturbances in transcatheter aortic valve replacement recipients: a systematic review and meta-analysis[J]. Eur Heart J, 2020, 41(29):2771-2781.
[13]
Fadahunsi OO, Olowoyeye A, Ukaigwe A, et al. Incidence, predictors, and outcomes of permanent pacemaker implantation following transcatheter aortic valve replacement: analysis from the U.S. Society of Thoracic Surgeons/American College of Cardiology TVT Registry[J]. JACC Cardiovasc Interv, 2016, 9(21):2189-2199.
[14]
Kapadia SR, Wazni O, Krishnaswamy A. pacemaker implantation after TAVR[J]. JACC Cardiovasc Imaging, 2017, 10(10 Pt A):1148-1150.
[15]
Eschenbach LK, Erlebach M, Deutsch MA, et al. Stroke after transcatheter aortic valve replacement: a severe complication with low predictability[J]. Catheter Cardiovasc Interv, 2022, 99(6):1897-1905.
[1] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[2] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[3] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[4] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[5] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[6] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[7] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[8] 许杰, 李亚俊, 冯义文. SOX新辅助化疗后腹腔镜胃癌D2根治术与常规根治术治疗进展期胃癌的近期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 647-650.
[9] 康婵娟, 张海涛, 翟静洁. 胰管支架置入术治疗急性胆源性胰腺炎的效果及对患者肝功能、炎症因子水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 667-670.
[10] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[11] 刘柏隆, 周祥福. 女性尿失禁吊带手术并发症处理的经验分享[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 127-127.
[12] 嵇振岭, 陈杰, 唐健雄. 重视复杂腹壁疝手术并发症的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 601-606.
[13] 江志鹏, 钟克力, 陈双. 复杂腹壁疝手术后腹腔高压与腹腔间室综合征的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 612-615.
[14] 王学虎, 赵渝. 复杂腹壁疝手术中血管损伤并发症的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 616-619.
[15] 石阳, 于剑锋, 曹可, 翟志伟, 叶春祥, 王振军, 韩加刚. 可扩张金属支架置入联合新辅助化疗治疗完全梗阻性左半结肠癌围手术期并发症分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 464-471.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?